|
|
130A Veritas In Silico Inc.
|
|
07/03/2025 15:30 |
Mitsubishi Gas Chemical and VIS Announce Joint Research Agreement for Drug Discovery and Establishment of Manufacturing Methods for Nucleic Acid Drugs |
06/16/2025 16:30 |
Determination of Target Disease for mRNA-Targeted Nucleic Acid Drug for In-house Pipeline |
05/23/2025 13:00 |
Shionogi and Veritas In Silico Announce Milestone Achievement in Joint Drug Discovery Research of mRNA-targeted Small Molecules |
05/09/2025 16:00 |
Financial Results - Fiscal Year Ended December 31,2025, 1st Quarter |
05/09/2025 16:00 |
Non-consolidated Financial Results for the Three Months Ended March 31,2025 [Under Japanese GAAP] |
02/20/2025 17:00 |
Organizational Reforms and Personnel Changes |
02/20/2025 17:00 |
Appointing Candidates for Director and Alternate Audit & Supervisory Board Member |
02/20/2025 17:00 |
Reduction of Capital Stock (Capital Reduction) |
02/13/2025 13:00 |
Company Presentation |
02/13/2025 13:00 |
Financial Results - Fiscal Year Ended December 31, 2024 |
02/13/2025 13:00 |
Non-consolidated Financial Results for the Fiscal Year Ended December 31, 2024 [Under Japanese GAAP] |
12/30/2024 10:00 |
Patent owned by Veritas In Silico to Become Effective in Europe |
12/23/2024 08:00 |
Liverpool ChiroChem and VIS to Enter into a Collaboration Development & Commercialization Agreement for mRNA-targeted Small Molecule Drugs |
12/13/2024 17:40 |
Company Presentation |
12/13/2024 17:30 |
Revised Financial Forecast for FY2024 |
11/13/2024 12:00 |
Organizational Reforms and Personnel Changes of General Managers |
11/13/2024 12:00 |
Fiscal Year Ending December 2024, 3rd Quarter, Financial Results |
11/13/2024 12:00 |
Non-consolidated Financial Results for the Nine Months Ended September 30, 2024 [Under Japanese GAAP] |
10/09/2024 14:00 |
Mitsubishi Gas Chemical and Veritas In Silico, Sign MOU on Joint Business of Research and Development of RNA-Targeted Drugs |
10/09/2024 08:30 |
Liverpool ChiroChem and Veritas In Silico Agree to Form a Strategic Partnership of mRNA-Targeted Drug Discovery and Development |
09/24/2024 12:00 |
Notification regarding Achievement of Milestone in Joint Drug Discovery Research with Shionogi & Co., Ltd. |
09/03/2024 15:05 |
[Delayed] Interim Financial Results - FY2024 1H |
08/05/2024 12:00 |
Non-consolidated Financial Results for the Six Months Ended June 30, 2024 [Under Japanese GAAP] |
|